Search Results - "KRAILO, M"

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment by Whelan, J.S., Bielack, S.S., Marina, N., Smeland, S., Jovic, G., Hook, J.M., Krailo, M., Anninga, J., Butterfass-Bahloul, T., Böhling, T., Calaminus, G., Capra, M., Deffenbaugh, C., Dhooge, C., Eriksson, M., Flanagan, A.M., Gelderblom, H., Goorin, A., Gorlick, R., Gosheger, G., Grimer, R.J., Hall, K.S., Helmke, K., Hogendoorn, P.C.W., Jundt, G., Kager, L., Kuehne, T., Lau, C.C., Letson, G.D., Meyer, J., Meyers, P.A., Morris, C., Mottl, H., Nadel, H., Nagarajan, R., Randall, R.L., Schomberg, P., Schwarz, R., Teot, L.A., Sydes, M.R., Bernstein, M., Pickering, James, Joffe, Nicola, Kevric, Matthias, Sorg, Benjamin, Villaluna, Doojduen, Wang, Caroline, Perisoglou, Martha, Trani, Leonardo, Potratz, Jenny, Carrle, Dorothe, Wilhelm, Miriam, Zils, Katja, Teske, Carmen

“…This manuscript describes the experience from registration until randomisation for a cohort of 2260 patients with osteosarcoma who joined the EURAMOS-1 trial…”
Get full text

Utility of frozen section in pediatric and adolescent malignant ovarian nonseminomatous germ cell tumors: A report from the children's oncology group by Dicken, B.J., Billmire, D.F., Rich, B., Hazard, F.K., Nuño, M., Krailo, M., Fallahazad, N., Pashankar, F., Shaikh, F., Frazier, A.L.

“…In adult women, most malignant ovarian tumors are epithelial in origin. The use of intra-operative frozen section to distinguish between benign and malignant…”
Get full text

International collaboration is feasible in trials for rare conditions: the EURAMOS experience by Marina, N, Bielack, S, Whelan, J, Smeland, S, Krailo, M, Sydes, M R, Butterfass-Bahloul, T, Calaminus, G, Bernstein, M

“…The introduction of multi-agent chemotherapy dramatically improved the outcome for patients with osteosarcoma. However, we appear to have reached a plateau in…”
Get more information

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group by Provisor, A J, Ettinger, L J, Nachman, J B, Krailo, M D, Makley, J T, Yunis, E J, Huvos, A G, Betcher, D L, Baum, E S, Kisker, C T, Miser, J S

“…The specific aims of this study were to improve event-free survival (EFS) in patients with newly diagnosed nonmetastatic osteosarcoma of an extremity using the…”
Get more information

Randomized Comparison of Cisplatin/Vincristine/Fluorouracil and Cisplatin/Continuous Infusion Doxorubicin for Treatment of Pediatric Hepatoblastoma: A Report From the Children’s Cancer Group and the Pediatric Oncology Group by ORTEGA, J. A, DOUGLASS, E. C, KRAILO, M. D, FEUSNER, J. H, REYNOLDS, M, QUINN, J. J, FINEGOLD, M. J, HAAS, J. E, KING, D. R, LIU-MARES, W, SENSEL, M. G

“…Previous studies demonstrated that chemotherapy with either cisplatin, vincristine, and fluorouracil (regimen A) or cisplatin and continuous infusion…”
Get full text

High-Dose Melphalan, Etoposide, Total-Body Irradiation, and Autologous Stem-Cell Reconstitution as Consolidation Therapy for High-Risk Ewing’s Sarcoma Does Not Improve Prognosis by MEYERS, Paul A, KRAILO, Mark D, HERZOG, Cynthia E, LINDSLEY, Karen L, LIU-MARES, Wen, NACHMAN, James B, SIEGER, Lance, WADMAN, Jean, GORLICK, Richard G, LADANYI, Marc, CHAN, Ka-Wah, SAILER, Scott L, DICKMAN, Paul S, BAKER, David L, DAVIS, Jeffrey H, GERBING, Robert B, GROVAS, Alfred

“…To determine whether consolidation therapy with high-dose melphalan, etoposide, and total-body irradiation (TBI) with autologous stem-cell support would…”
Get full text

Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors : a report from the Children's Oncology Group by WARREN, K, JAKACKI, R, OSBORNE, C, CEHELSKY, J, CALDWELL, D, STANWOOD, J, STEINBERG, S. M, BALIS, F. M, WIDEMANN, B, AIKIN, A, LIBUCHA, M, PACKER, R, VEZINA, G, REAMAN, G, SHAW, D, KRAILO, M

“…[corrected] Lobradimil is a synthetic bradykinin analog that rapidly and transiently increases the permeability of the blood-brain barrier (BBB). The…”
Get full text

Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms’ tumor: a Children’s Cancer Group report by Abu-Ghosh, A. M., Krailo, M. D., Goldman, S. C., Slack, R. S., Davenport, V., Morris, E., Laver, J. H., Reaman, G. H., Cairo, M. S.

“…Background The outcome of children with relapsed Wilms’ tumor is poor, especially with poor-risk factors such as unfavorable histology, early recurrence,…”
Get full text

Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group by Van Tornout, J M, Buckley, J D, Quinn, J J, Feusner, J H, Krailo, M D, King, D R, Hammond, G D, Ortega, J A

“…We analyzed data on 31 children with primary unresectable or metastatic hepatoblastoma (HB) to investigate possible prognostic correlations between the serum…”
Get more information

Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031 by Cuvelier, G D E, Kariminia, A, Fujii, H, Aslanian, S, Wall, D, Goldman, F, Grupp, S A, Dunn, S E, Krailo, M, Shapiro, L H, Gilman, A, Schultz, K R

“…Our group previously demonstrated a strong association between elevated plasma soluble CD13 enzyme activity and newly diagnosed extensive chronic GVHD (cGVHD)…”
Get full text

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma : A report of the children's cancer group by FROST, J. D, HANK, J. A, KRAILO, M. D, MATTHAY, K. K, REISFELD, R. A, SONDEL, P. M, REAMAN, G. H, FRIERDICH, S, SEEGER, R. C, GAN, J, ANDERSON, P. M, ETTINGER, L. J, CAIRO, M. S, BLAZAR, B. R

“…The murine monoclonal antibody (MoAb) 14.G2a recognizes GD2, a disialoganglioside expressed in tumors of neuroectodermal origin, and facilitates antibody…”
Get full text

Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a Children's Cancer Group Report by CAIRO, M. S, KRAILO, M. D, FINLAY, J. L, MEADOWS, A. T, MORSE, M, HUTCHINSON, R. J, HARRIS, R. E, KJELDSBERG, C. R, KADIN, M. E, RADEL, E, STEINHERZ, L. J, MORRIS, E

“…Despite prolonged therapy (18 months), children with advanced non-lymphoblastic, non-Hodgkin's lymphoma (NHL) treated on previous Children's Cancer Group (CCG)…”
Get full text

MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial by Hutchinson, R J, Fryer, C J, Davis, P C, Nachman, J, Krailo, M D, O'Brien, R T, Collins, R D, Whalen, T, Reardon, D, Trigg, M E, Gilchrist, G S

“…A randomized trial designed to compare mechlorethamine, vincristine, procarbazine, and prednisone (MOPP)/doxorubicin, bleomycin, vinblastine, and daccarbazine…”
Get more information

Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): A Children's Oncology Group Report by Angiolillo, Anne L., Whitlock, J., Chen, Z., Krailo, M., Reaman, G.

“…Background To determine the response rate and toxicity to gemcitabine administered as 10 mg/m2/min × 360 min weekly for 3 weeks in children with relapsed acute…”
Get full text

EWING SARCOMA OF THE RIB: RESULTS OF AN INTERGROUP STUDY WITH ANALYSIS OF OUTCOME BY TIMING OF RESECTION by Shamberger, Robert C, LaQuaglia, Michael P, Krailo, Mark D, Miser, James S, Pritchard, Douglas J, Gebhardt, Mark C, Healey, John H, Tarbell, Nancy J, Fryer, Christopher J.H, Meyers, Paul A, Grier, Holcombe E

“…We sought to establish the outcome and optimal therapeutic sequence for patients with nonmetastatic Ewing sarcoma/primitive neuroectodermal tumor of the chest…”
Get full text

Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study by Ozkaynak, M F, Sondel, P M, Krailo, M D, Gan, J, Javorsky, B, Reisfeld, R A, Matthay, K K, Reaman, G H, Seeger, R C

“…Ganglioside G(D2) is strongly expressed on the surface of human neuroblastoma cells. It has been shown that the chimeric human/murine anti-G(D2) monoclonal…”
Get full text

Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study by Tubergen, D G, Krailo, M D, Meadows, A T, Rosenstock, J, Kadin, M, Morse, M, King, D, Steinherz, P G, Kersey, J H

“…Patients with lymphoblastic non-Hodgkin's lymphoma (LB NHL) were randomized to treatment with either modified LSA2L2 or ADCOMP, which added daunorubicin (DAUN)…”
Get more information

Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial by Blaney, S M, Seibel, N L, O'Brien, M, Reaman, G H, Berg, S L, Adamson, P C, Poplack, D G, Krailo, M D, Mosher, R, Balis, F M

“…A phase I trial of docetaxel was performed to determine the maximum-tolerated dose (MTD), the dose-limiting toxicities, and the incidence and severity of other…”
Get more information

The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial by Skinner, D G, Daniels, J R, Russell, C A, Lieskovsky, G, Boyd, S D, Nichols, P, Kern, W, Sakamoto, J, Krailo, M, Groshen, S

“…We assigned 91 patients with deeply invasive, pathological stage P3, P4 or N+ and Mo transitional cell carcinoma of the bladder (with or without squamous or…”
Get more information

Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study by BLANEY, S. M, NEEDLE, M. N, BALIS, F. M, GILLESPIE, A, SATO, J. K, REAMAN, G. H, BERG, S. L, ADAMSON, P. C, KRAILO, M. D, BLEYER, W. A, POPLACK, D. G

“…The antitumor activity of topotecan administered as a 72-h continuous i.v. infusion was evaluated in children with refractory neuroblastoma and sarcomas of…”
Get full text